-
Is the class solidified? From Biotech to Pharma
Is the division of labor between Biotech and Pharma inevitable?
2023-02-07 15:32 -
Mabwell: The clinical trial application of 9MW2921 for injection was accepted by the State Food and ...
It has completely independent intellectual property rights.
2023-02-07 15:02 -
Eli Lilly Tirzepatide's Phase III trial in obese or overweight adult patients in China was successfu...
China joins the competition in the diet drug market.
2023-02-07 15:00 -
Focusing on hearing and balanced medicine, why did Shurui Medical break into the 10 billion market o...
Digital therapeutics help the rapid development of the auditory system.
2023-02-01 11:11 -
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT ...
A rookie in cell gene therapy products.
2023-02-01 11:10 -
Hua Quejing Medical has received tens of millions of yuan of exclusive investment from Shenzhen Vent...
The field of rehabilitation robots has ushered in heavy financing news
2023-02-01 11:09 -
Win exclusive orders of 100 billion! Zhifei Biotech and Merck renewed the supply, distribution and c...
Can the miracle of Zhifei Biology and Merck continue?
2023-02-01 11:08 -
Anti-aging drugs, saving 3 years stolen by the new crown
The new crown accelerates aging by 3-4 years.
2023-02-01 11:04 -
Cosmos Pharmaceutical Factory' has revenue of more than 100 billion US dollars in 2022, and 56.7 bil...
Pfizer announces 2022 earnings
2023-02-01 10:54 -
Why is the rate of prescription of Paxlovid to new crown patients by British and American doctors so...
Paxlovid's low prescription rate, where does it come from?
2023-01-29 14:56
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- Covestro and Wanhua Reshape Gl... Aug 20, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products